United Capital Management of KS Inc. Buys 33,044 Shares of SPDR S&P Biotech ETF (NYSEARCA:XBI)

United Capital Management of KS Inc. grew its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 24.0% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 170,527 shares of the exchange traded fund’s stock after purchasing an additional 33,044 shares during the quarter. SPDR S&P Biotech ETF makes up about 3.7% of United Capital Management of KS Inc.’s holdings, making the stock its 5th largest position. United Capital Management of KS Inc.’s holdings in SPDR S&P Biotech ETF were worth $16,848,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently modified their holdings of XBI. Baker Avenue Asset Management LP purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at about $343,000. Guerra Pan Advisors LLC increased its position in shares of SPDR S&P Biotech ETF by 6.6% during the third quarter. Guerra Pan Advisors LLC now owns 7,752 shares of the exchange traded fund’s stock valued at $766,000 after acquiring an additional 480 shares during the last quarter. Sigma Planning Corp lifted its holdings in SPDR S&P Biotech ETF by 46.4% during the third quarter. Sigma Planning Corp now owns 11,924 shares of the exchange traded fund’s stock worth $1,178,000 after acquiring an additional 3,781 shares during the period. Atria Investments Inc boosted its position in SPDR S&P Biotech ETF by 2.1% in the third quarter. Atria Investments Inc now owns 9,016 shares of the exchange traded fund’s stock worth $891,000 after purchasing an additional 188 shares during the last quarter. Finally, Essex Savings Bank purchased a new position in SPDR S&P Biotech ETF in the third quarter worth $236,000.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $104.18 on Monday. The firm has a market cap of $7.94 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1 year low of $64.99 and a 1 year high of $104.22. The stock has a fifty day moving average price of $98.96 and a 200-day moving average price of $95.68.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.